Brain iron deposition analysis using susceptibility weighted imaging and its association with body iron level in patients with mild cognitive impairment
Authors:
Open Access
- 29 September 2017
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 16 (6) , 8209-8215
Abstract
The aim of the present study was to analyze brain and body iron levels among patients with mild cognitive impairment (MCI), Alzheimer's disease (AD), and normal controls (NCs). A total of 90 participants (30 MCI, 30 AD, 30 NC) were enrolled. Brain iron content was quantified using susceptibility weighted imaging (SWI). Phase values were used to calculate bilateral iron content in the hippocampus (HP), substantia nigra, red nucleus (RN), dentate nucleus (DN), caudate nucleus (CN), globus pallidus (GP), putamen (PUT), frontal white matter, temporal cortex (TC), and parietal cortex. Body iron indices, including serum iron, serum transferrin, ferritin and total iron binding capacity, were measured. Phase values of the left (L)‑DN, L‑CN, and bilateral PUT in the MCI group were significantly lower compared with NC group. Phase values of the right (R)‑RN, bilateral DN, and bilateral PUT in the AD group were significantly lower compared with the MCI group. Phase values of the bilateral HP, DN, RN, CN, GP, PUT, and L‑TC in the AD group were significantly lower compared with the NC group. Serum ferritin levels in the MCI and AD groups were significantly lower compared with the NC group. Only serum iron in the AD group was positively associated with iron content in the R‑HP. Brain iron deposition and body iron levels both increased in MCI and AD patients, however, excessive brain iron accumulation may have no association with body iron level. SWI was particularly effective at recognizing the presence of brain iron in the MCI and AD groups.Keywords
This publication has 28 references indexed in Scilit:
- Decreased Serum Hepcidin Concentration Correlates with Brain Iron Deposition in Patients with HBV-Related CirrhosisPLOS ONE, 2013
- Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered AggregationJournal of Biological Chemistry, 2011
- Serum Iron Parameters, HFE C282Y Genotype, and Cognitive Performance in Older Adults: Results From the FACIT StudyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Relationship between brain R2 and liver and serum Iron concentrations in elderly menMagnetic Resonance in Medicine, 2010
- Comparison of amyloid plaque contrast generated by T2‐weighted, T‐weighted, and susceptibility‐weighted imaging methods in transgenic mouse models of Alzheimer's diseaseMagnetic Resonance in Medicine, 2009
- Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imagingJournal of Magnetic Resonance Imaging, 2009
- A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brainsJournal of Neuroscience Research, 1992
- Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementiaActa Neuropathologica, 1990
- THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAINJournal of Neurochemistry, 1958
- ALZHEIMERʼS DISEASEJournal of Nervous & Mental Disease, 1953